Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (54978)	7/25/2006 7:45:10 PM
From: GARY P GROBBEL	Respond to of 120405

GBIW--up .07 to .27 on 72,000 biz.yahoo.com The rapid result assay test for Mad-Cow disease has the potential for testing 165 million cattle, slaughtered in sixteen countries, each year. Also, the chronic wasting disease tool can test millions of deer and elk. The worldwide market for these two tests is approximately $1.5 billion. The test is superior to its contemporaries, primarily because the test results can be delivered in only thirty minutes. Current tests require four to six hours for results, and must be done in an off-site lab, which in many cases takes several days. NOTE---165m cattle sooner or later will have to be tested ea YEAR...at this price....$.27 per sh....downside is slim, upside significant...financing will be needed at some point I am sure but still....gpg